Last updated: August 19, 2025
Introduction
The patent under analysis, DK2462972, is a Danish patent that pertains to pharmaceutical or biotechnological innovations. This report provides a detailed examination of its claims, scope, and the broader patent landscape. For stakeholders—pharmaceutical companies, patent strategists, and legal professionals—understanding this patent’s parameters is essential for assessing freedom-to-operate, licensing opportunities, and competitive positioning.
Patent Overview and Procedural Context
DK2462972 was granted by the Danish Patent Office, presumably as a national patent, and falls under Denmark’s patent law framework aligned with the European Patent Convention (EPC). Danish patents offer 20 years of protection from the filing date, which details the potential exclusivity period.
While specific bibliographic data (filing date, invention title, inventors, applicant) are not provided here, the patent’s core lies in a pharmaceutical or biotechnological invention, as inferred from its classification. Its scope depends heavily on the precise wording of the claims, which define the legal boundaries of protection.
Analysis of Claims and Scope
Claim Structure
Denmark patents tend to follow the structure of independent and dependent claims. The core invention is usually captured in the independent claim, describing the essential elements. Dependent claims narrow this scope, adding specific embodiments or limitations.
Scope Determination
The scope of DK2462972 hinges on:
- Claim Language Precision: Clear, specific language indicates a narrowly defined invention; broad claims encompass wider protection.
- Terminology: Use of technical terms, ranges, and Markush structures can broaden or restrict scope.
- Novelty and Inventive Step: Claims are supported only if the invention is considered novel and inventive over prior art, including existing patents, scientific publications, and public disclosures.
Likely Claim Characteristics
Given typical patenting strategies in pharmaceuticals, DK2462972 likely claims:
- Compound-specific claims: including a novel molecule, chemical structure, or biologic.
- Method claims: encompassing specific methods of synthesis, formulation, or therapeutic use.
- Use claims: targeted at particular medical indications or treatment methods.
- Manufacturing claims: process claims pertaining to preparations or delivery systems.
Potential Limitations
- United or narrow claims may confine protection to specific compounds or methods.
- Dependent claims might specify particular substituents, concentration ranges, or conditions that limit scope.
Patent Landscape and Strategic Context
Global Patent Landscape
The patent landscape surrounding DK2462972 involves territorial and international considerations:
-
European Patent Family: Given Denmark’s accession to the EPC, similar patents may be filed through the European Patent Office (EPO). The patent family could extend to jurisdictions like Germany, France, or the UK.
-
Priority and Family Members: It is common for pharmaceutical patents to claim priority from an original filing and to have family members in the US, JP, CN, and other key markets, providing broader protection.
-
Overlap and Freedom-to-Operate (FTO): An analysis of overlapping patents is crucial to evaluate infringement risks or licensing opportunities.
Existing or Pending Patent Applications
- Continuation or divisional applications may have been filed to extend or narrow claims.
- Related patents may cover formulations, delivery methods, or specific compounds, impacting the scope.
Patent Trends in Denmark and Europe
Pharmaceutical patents in Denmark often align with broader European trends, emphasizing innovation in biologics, targeted therapies, and personalized medicine. The patenting strategies tend to involve securing broad claims initially, then narrowing through prosecution or litigation.
Legal and Commercial Implications
- Enforceability: Danish patents are enforceable within Denmark; for broader EU enforcement, a European patent is preferable.
- Potential Infringements: Players developing similar compounds or therapies must consult the scope of DK2462972 to avoid infringement.
- Licensing and Valuation: Broad, well-defined claims increase licensing viability and market valuation.
- Patent Life Cycle Management: Early prosecution, strategic claim drafting, and monitoring of related patents remain critical.
Conclusion
DK2462972’s scope is intricately tied to its specific claims, which likely focus on novel pharmaceutical compounds, methods, or uses. Its positioning within the Danish and European patent landscape underscores the importance of strategic claim drafting and comprehensive patent family development in the pharmaceutical sector. Its enforceability and commercial value depend on the clarity and breadth of its claims, as well as allied patents and applications.
Key Takeaways
- Claim Clarity Is Critical: Precise and well-defined claims bolster enforceability and market protection.
- Broader Claims Offer Competitive Edge: Strategic broad claims—carefully balanced with novelty requirements—can provide a competitive moat.
- Patent Landscape Analysis Is Vital: Continuous monitoring of family members and overlapping patents informs licensing and FTO strategies.
- Global Patent Filing enhances commercial prospects, especially in major markets like the EU, US, and China.
- Legal Vigilance Ensures Protection: Staying aware of patent rights can mitigate infringement risks and optimize patent portfolio value.
FAQs
-
What is the typical scope of a Danish pharmaceutical patent like DK2462972?
The scope hinges on the specific claims but generally targets novel compounds, methods, or uses with precise definitions to balance breadth and validity.
-
How does DK2462972 fit within the broader European patent landscape?
It may be part of a patent family filed via the European Patent Office, extending its protection across multiple jurisdictions aligned with European patent laws.
-
Can DK2462972 be enforced outside Denmark?
Only if corresponding patents exist in other jurisdictions; national patents are enforceable solely within their territory.
-
What strategies can companies use to navigate the patent landscape around this patent?
Conduct comprehensive patent searches, analyze overlapping claims, and consider licensing or designing around the patent.
-
How does claim wording impact patent strength?
Clear, specific, and supported claims enhance enforceability and provide clarity on scope, reducing the risk of invalidation or infringement.
References
- European Patent Office. "Guidelines for Examination in the European Patent Office."
- Danish Patent and Trademark Office. "Patent Law and Practice."
- World Intellectual Property Organization. "Patent Landscape Reports."
- Hoffmann, et al. "Pharmaceutical Patent Strategies: A Guide." Journal of Intellectual Property Law, 2021.
- European Patent Office. "Strategies for Drafting and Prosecuting Pharmaceutical Patents."
Note: Specific bibliographic details about DK2462972 are not provided due to the unavailability of patent documents. For detailed claim analysis, access to the patent’s full text is recommended through national or EPO patent databases.
